These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 31616500)

  • 1. Clinical Presentation and Outcomes of Phaeochromocytomas/Paragangliomas in Neurofibromatosis Type 1.
    Al-Sharefi A; Javaid U; Perros P; Ealing J; Truran P; Nag S; Kamaruddin S; Abouglila K; Cains F; Lewis L; James RA
    Eur Endocrinol; 2019 Aug; 15(2):95-100. PubMed ID: 31616500
    [No Abstract]   [Full Text] [Related]  

  • 2. Phaeochromocytoma/paraganglioma and adverse clinical outcomes in patients with neurofibromatosis-1.
    Al-Sharefi A; Perros P; James RA
    Endocr Connect; 2018 Aug; 7(10):R254-9. PubMed ID: 30120202
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pheochromocytoma and paraganglioma in patients with neurofibromatosis type 1.
    Gruber LM; Erickson D; Babovic-Vuksanovic D; Thompson GB; Young WF; Bancos I
    Clin Endocrinol (Oxf); 2017 Jan; 86(1):141-149. PubMed ID: 27460956
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pheochromocytomas are diagnosed incidentally and at older age in neurofibromatosis type 1.
    Moramarco J; El Ghorayeb N; Dumas N; Nolet S; Boulanger L; Burnichon N; Lacroix A; Elhaffaf Z; Gimenez Roqueplo AP; Hamet P; Bourdeau I
    Clin Endocrinol (Oxf); 2017 Mar; 86(3):332-339. PubMed ID: 27787920
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management of metastatic phaeochromocytoma and paraganglioma: use of iodine-131-meta-iodobenzylguanidine therapy in a tertiary referral centre.
    Rutherford MA; Rankin AJ; Yates TM; Mark PB; Perry CG; Reed NS; Freel EM
    QJM; 2015 May; 108(5):361-8. PubMed ID: 25267727
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phaeochromocytoma: state-of-the-art.
    Donckier JE; Michel L
    Acta Chir Belg; 2010; 110(2):140-8. PubMed ID: 20514823
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Giant phaeochromocytoma presenting with an acute stroke: reappraising phaeochromocytoma surveillance for the neurofibromatosis type 1 phakomatosis.
    Lee Y; Tan LYR; Ho YH; Leow MKS
    BMJ Case Rep; 2017 Nov; 2017():. PubMed ID: 29102976
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Higher risk of phaeochromocytoma/paraganglioma (Phaeo-Pgl) in SDHD than SDHB carriers: an Australian cohort study.
    Hong A; Shanahan M; Schenberg T; Inder W; MacIsaac R; James P; Sachithanandan N
    Intern Med J; 2019 Apr; 49(4):529-532. PubMed ID: 30957378
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 15 YEARS OF PARAGANGLIOMA: The association of pituitary adenomas and phaeochromocytomas or paragangliomas.
    O'Toole SM; Dénes J; Robledo M; Stratakis CA; Korbonits M
    Endocr Relat Cancer; 2015 Aug; 22(4):T105-22. PubMed ID: 26113600
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Does iodine-131 meta-iodobenzylguanidine (MIBG) scintigraphy have an impact on the management of sporadic and familial phaeochromocytoma?
    Taïeb D; Sebag F; Hubbard JG; Mundler O; Henry JF; Conte-Devolx B
    Clin Endocrinol (Oxf); 2004 Jul; 61(1):102-8. PubMed ID: 15212651
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phaeochromocytoma in multiple endocrine neoplasia type 2: RET codon-specific penetrance and changes in management during the last four decades.
    Mucha L; Leidig-Bruckner G; Frank-Raue K; Bruckner T; Kroiss M; Raue F;
    Clin Endocrinol (Oxf); 2017 Oct; 87(4):320-326. PubMed ID: 28605116
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differences between sporadic and multiple endocrine neoplasia type 2A phaeochromocytoma.
    Pomares FJ; Cañas R; Rodriguez JM; Hernandez AM; Parrilla P; Tebar FJ
    Clin Endocrinol (Oxf); 1998 Feb; 48(2):195-200. PubMed ID: 9579232
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dopamine-secreting phaeochromocytomas and paragangliomas: clinical features and management.
    Foo SH; Chan SP; Ananda V; Rajasingam V
    Singapore Med J; 2010 May; 51(5):e89-93. PubMed ID: 20593136
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Next-generation panel sequencing identifies
    Gieldon L; Masjkur JR; Richter S; Därr R; Lahera M; Aust D; Zeugner S; Rump A; Hackmann K; Tzschach A; Januszewicz A; Prejbisz A; Eisenhofer G; Schrock E; Robledo M; Klink B
    Eur J Endocrinol; 2018 Feb; 178(2):K1-K9. PubMed ID: 29158289
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Are patients with hormonally functional phaeochromocytoma and paraganglioma initially receiving a proper adrenoceptor blockade? A retrospective cohort study.
    Luiz HV; Tanchee MJ; Pavlatou MG; Yu R; Nambuba J; Wolf K; Prodanov T; Wesley R; Adams K; Fojo T; Pacak K
    Clin Endocrinol (Oxf); 2016 Jul; 85(1):62-9. PubMed ID: 26998836
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictive value of café au lait macules at initial consultation in the diagnosis of neurofibromatosis type 1.
    Nunley KS; Gao F; Albers AC; Bayliss SJ; Gutmann DH
    Arch Dermatol; 2009 Aug; 145(8):883-7. PubMed ID: 19687418
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rupture of the Left External Iliac Artery and Right Groin Pseudoaneurysm Formation following Angioplasty in a Patient with Neurofibromatosis Type 1 and Undiagnosed Bilateral Phaeochromocytoma.
    Doleman B; Kaushal S; Patel A; Kirk J; Quarmby J
    Case Rep Radiol; 2013; 2013():526421. PubMed ID: 23984157
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phaeochromocytoma, new genes and screening strategies.
    Gimenez-Roqueplo AP; Lehnert H; Mannelli M; Neumann H; Opocher G; Maher ER; Plouin PF;
    Clin Endocrinol (Oxf); 2006 Dec; 65(6):699-705. PubMed ID: 17121518
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optic Gliomas in Neurofibromatosis Type 1.
    Parkhurst E; Abboy S
    J Pediatr Ophthalmol Strabismus; 2016 Nov; 53(6):334-338. PubMed ID: 27537249
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical characteristics and long-term outcomes of moyamoya syndrome associated with neurofibromatosis type 1.
    Han C; Yang WZ; Zhang HT; Ye T; Duan L
    J Clin Neurosci; 2015 Feb; 22(2):286-90. PubMed ID: 25443089
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.